Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 2cureX 2CUREX May 15, 2026 1.98 +1.54   
 36 Group 36GRP May 15, 2026 0.12 +8.85   
 4C Group AB 4C May 15, 2026 6.95 -2.11   
 AAC Clyde Space AAC May 15, 2026 132.00 -0.30   
 AAK AAK May 15, 2026 264.00 +0.15   
 ABAS Protect AB ABAS May 15, 2026 7.30 0.00   
 ABB ABB May 15, 2026 983.80 +0.41   
 Abelco Investment Group ABIG May 15, 2026 0.00 0.00   
 Abera Bioscience ABERA May 15, 2026 6.84 +3.64   
 Absolent Air Care Group ABSO May 15, 2026 201.00 +1.01   
 Absolicon B ABSLB May 15, 2026 6.00 +13.21   
 AcadeMedia ACAD May 15, 2026 104.60 +0.38   
 Acarix ACARIX May 15, 2026 0.26 +0.19   
 Acast ACAST May 15, 2026 34.85 -0.14   
 Acconeer ACCON May 15, 2026 14.54 -3.20   
 Acenta Group PADEL May 15, 2026 3.66 +3.98   
 AcouSort ACOU May 15, 2026 4.79 +8.62   
 Acrinova A ACRIA May 15, 2026 8.90 -1.11   
 Acrinova B ACRIB May 15, 2026 8.98 -3.23   
 ACROUD ACROUD May 15, 2026 0.14 -6.21   
 Actic Group ATIC May 15, 2026 32.50 -1.07   
 Active Biotech ACTI May 15, 2026 0.07 +5.45   
 AcuCort ACUC May 15, 2026 0.71 +1.72   
 Acuvi AB ACUVI May 15, 2026 11.16 +4.89   
 AddLife B ALIFB May 15, 2026 144.70 -1.23   
 Addnode Group B ANODB May 15, 2026 45.85 +0.66   
 Addtech B ADDTB May 15, 2026 323.60 -0.61   
 Adtraction ADTR May 15, 2026 37.90 -1.30   
 Advenica ADVE May 15, 2026 23.25 +0.87   
 Adverty ADVT May 15, 2026 0.10 -4.95   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.